|
ES2542328T3
(es)
*
|
2002-12-06 |
2015-08-04 |
Millennium Pharmaceuticals, Inc. |
Métodos para la identificación, evaluación y tratamiento de pacientes con terapia de inhibición del proteasoma
|
|
CA2553551C
(en)
|
2004-01-21 |
2020-12-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for determining a graft tolerant phenotype in a subject
|
|
CA2563074C
(en)
|
2004-04-09 |
2014-05-20 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
USRE46843E1
(en)
|
2005-03-14 |
2018-05-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for evaluating graft survival in a solid organ transplant recipient
|
|
EP2604703B1
(en)
|
2005-03-14 |
2017-02-01 |
The Board of Trustees of the Leland Stanford Junior University |
Methods for evaluating graft survival in a solid organ transplant recipient
|
|
CA2611728A1
(en)
|
2005-06-08 |
2006-12-14 |
Millennium Pharmaceuticals, Inc. |
Methods for the identification, assessment, and treatment of patients with cancer therapy
|
|
WO2007001943A2
(en)
*
|
2005-06-20 |
2007-01-04 |
The Regents Of The University Of California |
Prefoldin 4 in the treatment and diagnosis of cancer
|
|
EP1991701A4
(en)
*
|
2006-02-14 |
2010-03-17 |
Dana Farber Cancer Inst Inc |
COMPOSITIONS, KITS AND METHODS OF IDENTIFICATION, ASSESSMENT, PREVENTION AND THERAPY OF CANCER
|
|
EP2046973A4
(en)
*
|
2006-08-10 |
2010-04-07 |
Millennium Pharm Inc |
IDENTIFICATION, ASSESSMENT AND TREATMENT OF CANCER THERAPY PATIENTS
|
|
EP2171090B1
(en)
*
|
2007-06-08 |
2013-04-03 |
Genentech, Inc. |
Gene expression markers of tumor resistance to her2 inhibitor treatment
|
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
|
US20080317768A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Boeing Company |
Bioconjugated nanoparticles
|
|
WO2009042676A1
(en)
*
|
2007-09-24 |
2009-04-02 |
University Of South Florida |
Method for early detection of cancers
|
|
US20090094047A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and methods for predicting a risk utilizing epigenetic data
|
|
US20090094261A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Jung Edward K Y |
Systems and methods for correlating epigenetic information with disability data
|
|
US20100027780A1
(en)
*
|
2007-10-04 |
2010-02-04 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and methods for anonymizing personally identifiable information associated with epigenetic information
|
|
US20090094282A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems and methods for correlating past epigenetic information with past disability data
|
|
US20090099877A1
(en)
*
|
2007-10-11 |
2009-04-16 |
Hyde Roderick A |
Systems and methods for underwriting risks utilizing epigenetic information
|
|
US20090094065A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Hyde Roderick A |
Systems and methods for underwriting risks utilizing epigenetic information
|
|
US20090100095A1
(en)
*
|
2007-10-04 |
2009-04-16 |
Jung Edward K Y |
Systems and methods for reinsurance utilizing epigenetic information
|
|
US20090094067A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Searete LLC, a limited liability corporation of |
Systems and methods for company internal optimization utilizing epigenetic data
|
|
US20090094281A1
(en)
*
|
2007-10-04 |
2009-04-09 |
Jung Edward K Y |
Systems and methods for transferring combined epigenetic information and other information
|
|
MX2010005080A
(es)
|
2007-11-07 |
2010-07-28 |
Genentech Inc |
Metodos y composiciones para determinar la sensibilidad de linfoma de celula b al tratamiento con anticuerpos anti-cd40.
|
|
DK2568053T3
(da)
*
|
2008-05-12 |
2014-07-21 |
Genomic Health Inc |
Tests til forudsigelse af cancerpatienters respons på forskellige kemoterapeutiske behandlingsmuligheder
|
|
WO2010021696A1
(en)
*
|
2008-08-18 |
2010-02-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for determining a graft tolerant phenotype in a subject
|
|
US7657446B1
(en)
|
2008-08-22 |
2010-02-02 |
Numoda Technologies, Inc. |
Automated identification of tasks that must be completed before a clinical trial database can be locked
|
|
RU2011111532A
(ru)
*
|
2008-08-28 |
2012-10-10 |
Онкотерапи Сайенс, Инк. (Jp) |
Твс1d7 в качестве опухолевого маркера и терапевтической мишени в случае злокачественной опухоли
|
|
US20100169115A1
(en)
*
|
2008-12-31 |
2010-07-01 |
Tamis Robert H |
System for matching individuals with health care providers and methods thereof
|
|
EP2387618B1
(en)
|
2009-01-15 |
2014-05-21 |
The Board of Trustees of The Leland Stanford Junior University |
Biomarker panel for diagnosis and prediction of graft rejection
|
|
TW201030337A
(en)
*
|
2009-02-04 |
2010-08-16 |
Tzu Chi Buddhist General Hospital |
Method and kit for detecting cancers
|
|
AU2010223919B2
(en)
|
2009-03-13 |
2016-03-31 |
Les Laboratoires Servier |
Methods and compositions for cell-proliferation-related disorders
|
|
KR101787768B1
(ko)
*
|
2009-04-18 |
2017-10-18 |
제넨테크, 인크. |
항-ｃｄ４０ 항체를 사용한 치료에 대한 ｂ-세포 림프종의 반응성 평가를 위한 방법
|
|
RU2561132C2
(ru)
|
2009-06-29 |
2015-08-20 |
Аджиос Фармасьютикалз, Инк. |
Производные хинолинсульфонамидов и их применение для модулирования пкм2 активности
|
|
CA2767616A1
(en)
|
2009-07-09 |
2011-01-13 |
The Scripps Research Institute |
Gene expression profiles associated with chronic allograft nephropathy
|
|
US20120252028A1
(en)
*
|
2009-08-14 |
2012-10-04 |
Michael Shtulman |
Target genes for cancer therapy
|
|
EP3561077B1
(en)
|
2009-10-21 |
2022-12-21 |
Les Laboratoires Servier |
Methods for cell-proliferation-related disorders
|
|
WO2011050211A2
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
US9493833B1
(en)
*
|
2009-11-06 |
2016-11-15 |
The Regents Of The University Of California |
Methods for preventing induced synthesis of proteasomes in human cells
|
|
US20120231472A1
(en)
*
|
2009-11-07 |
2012-09-13 |
Astute Medical, Inc. |
Methods and compositions for diagnosis and prognosis of renal injury and renal failure
|
|
US9290813B2
(en)
|
2009-12-02 |
2016-03-22 |
The Board Of Trustees Of The Leland Stanford Junior University |
Biomarkers for determining an allograft tolerant phenotype
|
|
EP3178944B1
(en)
|
2010-01-11 |
2019-05-15 |
Genomic Health, Inc. |
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
|
|
WO2011119980A1
(en)
|
2010-03-25 |
2011-09-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protein and gene biomarkers for rejection of organ transplants
|
|
US20110236582A1
(en)
|
2010-03-29 |
2011-09-29 |
Scheuing David R |
Polyelectrolyte Complexes
|
|
US9309435B2
(en)
|
2010-03-29 |
2016-04-12 |
The Clorox Company |
Precursor polyelectrolyte complexes compositions comprising oxidants
|
|
JP2013526863A
(ja)
*
|
2010-05-13 |
2013-06-27 |
ユニバーシテート チューリッヒ |
バイオマーカーとして用いるための不連続状態
|
|
MX338883B
(es)
|
2010-07-27 |
2016-05-04 |
Genomic Health Inc |
Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata.
|
|
US20140322705A1
(en)
*
|
2010-08-20 |
2014-10-30 |
Thomas Jefferson University |
Cancer diagnostic and cancer therapeutic
|
|
WO2012139051A2
(en)
|
2011-04-06 |
2012-10-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Autoantibody biomarkers for iga nephropathy
|
|
SG194697A1
(en)
|
2011-05-03 |
2013-12-30 |
Agios Pharmaceuticals Inc |
Pyruvate kinase activators for use in therapy
|
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
MX357429B
(es)
|
2011-08-11 |
2018-07-09 |
Janssen Pharmaceutica Nv |
Predictores para el tratamiento del cáncer.
|
|
EP2771489B1
(en)
*
|
2011-10-28 |
2018-07-04 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to nae inhibitors
|
|
CA2855368A1
(en)
*
|
2011-11-11 |
2013-05-16 |
Millennium Pharmaceuticals, Inc. |
Biomarkers of response to proteasome inhibitors
|
|
NZ627096A
(en)
|
2012-01-06 |
2017-02-24 |
Agios Pharmaceuticals Inc |
Triazinyl compounds and their methods of use
|
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
|
CA2862320A1
(en)
*
|
2012-01-24 |
2013-08-01 |
Millennium Pharmaceuticals, Inc. |
Method of treatment of nasopharyngeal cancer
|
|
JP6215235B2
(ja)
*
|
2012-01-24 |
2017-10-18 |
ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． |
癌の治療方法
|
|
GB2523211B
(en)
|
2012-01-27 |
2020-03-18 |
Univ Jefferson |
MCT protein inhibitor-related prognostic and therapeutic methods
|
|
US8725426B2
(en)
|
2012-01-31 |
2014-05-13 |
Genomic Health, Inc. |
Gene expression profile algorithm and test for determining prognosis of prostate cancer
|
|
WO2014062511A1
(en)
|
2012-10-15 |
2014-04-24 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
|
ES2702183T3
(es)
*
|
2013-03-15 |
2019-02-27 |
Mayo Found Medical Education & Res |
Identificación y monitorización de inmunoglobulinas monoclonales por masa molecular
|
|
WO2014172627A1
(en)
|
2013-04-19 |
2014-10-23 |
Thomas Jefferson University |
Caveolin-1 related methods for treating glioblastoma with temozolomide
|
|
JP2016521979A
(ja)
|
2013-05-30 |
2016-07-28 |
ジェノミック ヘルス， インコーポレイテッド |
腎臓がんを有する患者に対する再発スコアを計算するための遺伝子発現プロファイルアルゴリズム
|
|
CN105593215B
(zh)
|
2013-07-11 |
2019-01-15 |
安吉奥斯医药品有限公司 |
用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
|
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
WO2015003355A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
|
EA038246B1
(ru)
*
|
2013-08-08 |
2021-07-29 |
Оникс Терапьютикс, Инк. |
Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом
|
|
KR20240010105A
(ko)
|
2014-03-14 |
2024-01-23 |
아지오스 파마슈티컬스 아이엔씨. |
치료적으로 활성인 화합물의 약제학적 조성물
|
|
WO2015154052A1
(en)
|
2014-04-04 |
2015-10-08 |
Mayo Foundation For Medical Education And Research |
Isotyping immunoglobulins using accurate molecular mass
|
|
CN106414726A
(zh)
|
2014-04-07 |
2017-02-15 |
米纳瓦生物技术公司 |
抗nme抗体
|
|
US11104951B2
(en)
|
2014-05-22 |
2021-08-31 |
The Scripps Research Institute |
Molecular signatures for distinguishing liver transplant rejections or injuries
|
|
US10443100B2
(en)
|
2014-05-22 |
2019-10-15 |
The Scripps Research Institute |
Gene expression profiles associated with sub-clinical kidney transplant rejection
|
|
US20160018414A1
(en)
*
|
2014-07-21 |
2016-01-21 |
The Florida International University Board Of Trustees |
SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers
|
|
EP3175242A4
(en)
|
2014-07-29 |
2017-12-27 |
Mayo Foundation for Medical Education and Research |
Quantifying monoclonal antibody therapeutics by lc-ms/ms
|
|
WO2016161153A2
(en)
*
|
2015-04-01 |
2016-10-06 |
The Regents Of The University Of California |
Prognostic and diagnostic methods for colorectal cancer
|
|
FI3307271T3
(fi)
|
2015-06-11 |
2023-10-17 |
Agios Pharmaceuticals Inc |
Pyruvaattikinaasin aktivaattorien käyttämisen menetelmä
|
|
CN108026164A
(zh)
|
2015-09-24 |
2018-05-11 |
梅约医学教育与研究基金会 |
通过质谱鉴定免疫球蛋白游离轻链
|
|
PT3362066T
(pt)
|
2015-10-15 |
2021-11-16 |
Celgene Corp |
Terapia de combinação para tratar malignidades
|
|
SG11201803088PA
(en)
|
2015-10-15 |
2018-05-30 |
Agios Pharmaceuticals Inc |
Combination therapy for treating malignancies
|
|
EP3377646A1
(en)
*
|
2015-11-20 |
2018-09-26 |
Université de Strasbourg |
Method for identifying personalized therapeutic strategies for patients affected with a cancer
|
|
MX391039B
(es)
*
|
2016-04-07 |
2025-03-21 |
Univ Leland Stanford Junior |
Diagnostico no invasivo por medio de la secuenciacion del adn libre de celulas 5-hidroxi-metilado.
|
|
US20170298422A1
(en)
|
2016-04-18 |
2017-10-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Simultaneous single-molecule epigenetic imaging of dna methylation and hydroxymethylation
|
|
AU2017325022B2
(en)
|
2016-09-07 |
2022-10-13 |
Mayo Foundation For Medical Education And Research |
Identification and monitoring of cleaved immunoglobulins by molecular mass
|
|
CN118271442A
(zh)
|
2016-12-23 |
2024-07-02 |
蓝鳍生物医药公司 |
抗sez6l2抗体和抗体药物缀合物
|
|
EP3655553B1
(en)
*
|
2017-07-21 |
2022-03-23 |
Liquid Biopsy Research LLC |
Methods for detection of plasma cell dyscrasia
|
|
EP3681907A4
(en)
|
2017-09-13 |
2021-07-07 |
Mayo Foundation for Medical Education and Research |
IDENTIFICATION AND MONITORING OF IMMUNOGLOBULIN J-CHAINS
|
|
WO2019055634A1
(en)
|
2017-09-13 |
2019-03-21 |
Mayo Foundation For Medical Education And Research |
IDENTIFICATION AND MONITORING OF A MACROPHAGE APOPTOSIS INHIBITOR
|
|
US20190233900A1
(en)
*
|
2018-02-01 |
2019-08-01 |
Nantomics, Llc |
Biomarkers in de novo pyrimidine synthesis pathways and chemoresistance
|
|
WO2019222553A1
(en)
|
2018-05-16 |
2019-11-21 |
Forma Therapeutics, Inc. |
Inhibiting mutant idh-1
|
|
US11013733B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)
|
|
US11013734B2
(en)
|
2018-05-16 |
2021-05-25 |
Forma Therapeutics, Inc. |
Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutation
|
|
US10532047B2
(en)
|
2018-05-16 |
2020-01-14 |
Forma Therapeutics, Inc. |
Solid forms of ((S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
|
|
US11311527B2
(en)
|
2018-05-16 |
2022-04-26 |
Forma Therapeutics, Inc. |
Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)
|
|
US10769307B2
(en)
|
2018-05-30 |
2020-09-08 |
Bank Of America Corporation |
Processing system using natural language processing for performing dataset filtering and sanitization
|
|
EP3810284A4
(en)
*
|
2018-06-01 |
2022-06-15 |
Lunella Biotech, Inc. |
BIOMARKERS AND THERAPEUTICS IN RESISTANCE TO ENDOCRINE THERAPY
|
|
US10980788B2
(en)
|
2018-06-08 |
2021-04-20 |
Agios Pharmaceuticals, Inc. |
Therapy for treating malignancies
|
|
CN109190713A
(zh)
*
|
2018-09-29 |
2019-01-11 |
王海燕 |
基于血清质谱自适应稀疏特征选择的卵巢癌微创快检技术
|
|
SG10201811119XA
(en)
*
|
2018-12-12 |
2020-07-29 |
Sengenics Sdn Bhd |
Detection of biomarkers for non-small cell lung cancer
|
|
CN109633142B
(zh)
*
|
2018-12-22 |
2021-08-27 |
中国人民解放军第四军医大学 |
一种急性髓细胞性白血病诊断模型的建立方法及其应用
|
|
US20220081727A1
(en)
*
|
2019-01-17 |
2022-03-17 |
Geninus Inc. |
Biomarker for predicting response to anticancer agent and use thereof
|
|
EP3920693A4
(en)
|
2019-02-04 |
2022-10-05 |
Minerva Biotechnologies Corporation |
ANTI-NME ANTIBODIES AND METHODS OF TREATMENT OF CANCER OR CANCER METASTASIS
|
|
WO2020206015A1
(en)
*
|
2019-04-02 |
2020-10-08 |
Northwestern University |
Markers of efficacy of topoisomerase poisons
|
|
US20220290243A1
(en)
*
|
2019-07-01 |
2022-09-15 |
Rutgers, The State University Of New Jersey |
Identification of patients that will respond to chemotherapy
|
|
WO2021030604A1
(en)
*
|
2019-08-14 |
2021-02-18 |
University Of Massachusetts |
Urinary rna signatures in renal cell carcinoma (rcc)
|
|
WO2021108043A1
(en)
|
2019-11-27 |
2021-06-03 |
University Of Cincinnati |
Assessing treatment response with estimated number of tumor cells
|
|
RU2750103C1
(ru)
*
|
2020-02-21 |
2021-06-22 |
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации |
Способ дифференциальной диагностики диффузных в-клеточных крупноклеточных лимфом
|
|
CN116367857A
(zh)
|
2020-06-08 |
2023-06-30 |
米纳瓦生物技术公司 |
抗nme抗体及治疗癌症或癌症转移的方法
|
|
KR20230028796A
(ko)
|
2020-06-26 |
2023-03-02 |
미네르바 바이오테크놀로지 코포레이션 |
항-nme 항체 및 암 또는 암 전이의 치료 방법
|
|
CN112501278A
(zh)
*
|
2020-12-03 |
2021-03-16 |
中国医学科学院病原生物学研究所 |
Smim26作为结核病诊断分子标识的用途
|
|
CN113092757B
(zh)
*
|
2021-02-23 |
2024-02-06 |
承德医学院 |
一种肺癌肝转移早期诊断试剂盒及制备使用方法
|
|
CN115372618B
(zh)
*
|
2022-09-19 |
2025-01-14 |
首都医科大学附属北京胸科医院 |
一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用
|
|
CN116500266B
(zh)
*
|
2023-03-07 |
2025-06-17 |
南通大学附属医院 |
MRPS21基因及其RNAi干扰系统的应用
|